Presenting Companies

Octane portfolio companies pitch their products to our investor ecosystem with key strategics and physicians.

Octane presents two awards: the People’s Choice Award and the Judge’s Choice Award.


Triple Hair – 2024 Judge’s Choice Award Recipient

Trufacial – 2024 People’s Choice Award Recipient

2024 Presenting Companies


Regenerative and aesthetic medicine company developing products for tissue regeneration


CollPlant is a regenerative and aesthetic medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing. Our revolutionary plant-based technology is the only commercially viable technology for mass production of recombinant human Type I collagen (rhCollagen), which is identical to the collagen produced by the human body.


Redefining medical aesthetics and wound care through first-in-class cosmeceuticals


DREAMADERM, Inc. is a trailblazing medical aesthetics and wound care company predicated on a revolutionary new approach to maximizing collagen production. Our core technology, Dermatrix, is a patented, first-in-class protease inhibitor that stimulates collagen production through an entirely novel mechanism of action.


Lionheart Health regenerative aesthetics & healthspan technologies


Lionheart Health, a global leader in regenerative aesthetics and healthspan longevity tech, boasts 700+ patents in bioelectric-controlled protein expressions. Their R&D Lab in Irvine, California focuses on breakthroughs in regenerative medicine. Lionheart is in the $101M XPrize for Healthspan extension, featuring klotho expression for muscle growth and anti-aging. Products include SkinStim for skin regeneration, HairCell for hair regrowth, and ErectiStim for sexual health. A partnership with AcuLab Life Sciences involves klotho blood testing. Plans include opening Lionheart Longevity MedSpas globally, starting in March 2024.


Regenerative medicine company leading the world in autologous fat and tissue cryo-storage


T&CT is the only company in the world that is able to freeze and thaw large volumes of human fat (litres…) over prolonged periods (years…), while preserving exceptionally high levels of cell and tissue viability through the cryo-storage and post-thaw. Typically our process provides cell viability rates of 75-85% post thaw, while most other teams and groups might manage rates in the 25-35% range. Our platform technology is a major advance and has been recognised by leading surgeons and researchers in the UK, US and EU. We have been providing this service commercially to major UK hospitals since 2016, with exceptional outcomes.


Revolutionizing Alopecia Treatment


Triple Hair, a clinical-stage Canadian biotechnology company, is at the forefront of developing groundbreaking treatments for alopecia. Explore their advancements and witness the potential for transformative solutions in addressing hair loss.


Perfecting Skin Health, Anytime, Anywhere


TruFacial delivers instant results and encourages skin to rebound from visible damage, ultimately leading to a refined and improved appearance. With consistent use, experience enduring outcomes that promise a sustained radiance and transformation in skin texture.

Why You Should Apply to Present at Octane Signature Events:

  1. Access to the Industry Elite: The Aesthetics Tech Forum brings together top physicians, entrepreneurs, and investors in the field. This is your chance to make connections and receive feedback from the industry’s most influential players.
  2. Visibility and Credibility: Pitching at our Forum not only puts your company in the spotlight but also boosts your credibility. Gain recognition from peers, investors, and potential partners.
  3. Mentorship and Resources: Selected companies will have the opportunity to meet with Octane’s Capital Assist & LaunchPad SBDC Accelerator teams, offering mentorship, resources, and a clear path to growth.

2023 Presenting Companies


Lumisque Skincare presents CO2Lift, a medical-grade brand of super hydrating treatments that delivers Carbon Dioxide to lift, tighten and regenerate the skin. Two transdermal carboxy products featured: CO2Lift Pro, a facial and body treatment mask, and CO2LiftV an at-home vulva/vaginal treatment that helps to lessen the symptoms which are due to inadequate lubrication and lowered estrogen levels, without pain nor downtime. It helps improve natural lubrication and increase sensation during sex. The CO2liftPro and CO2LiftV are used as stand-alone or in combination with procedures that will improve results and reduce downtime.

Presenter: Lana Kerr, CEO

Learn More. 


RealizeMD – an AI-driven medical visual data platform based on real results – Real Results Anonymized. Our proprietary algorithms (Anonymizer, Realizer, Verifier) enable privacy preserving visualization, allowing clinics to use ‘before & after’ visuals of reconstructive and cosmetic procedures while safeguarding patient’s privacy. Our Platform will dramatically increase the candidate participation rates in plastic surgery, dental and medical aesthetics procedures, using AI-based visualization. We’re creating a new language for visual results, by liberating highly regulated visual data. Founded in April 2020 by industry veterans, we’ve released 2 MVPs, RealizeMD SHOW and ANALYZE. We’re looking to raise our Seed/A round to expand development and market penetration.

Presenter: Uri Neeman, CEO

Learn More.


Spiderwort is a biomaterials company that develops cellulose-based scaffolds for use in regenerative medicine. Its proprietary biomaterial platform consists of the isolation and manufacturing of a repertoire of unique, plant tissue-derived microstructures matching target tissue extracellular matrix structure. A leading application for these biomaterials includes soft tissue augmentation for aesthetic enhancement. Spiderwort aims to disrupt the dermal filler market through the introduction of CelluJuve TM, a long-lasting dermal filler for nasolabial fold remediation and mid-cheek applications (acne scar filling, lipoatrophy). Another core application for these biomaterials is in spinal cord injury (SCI) repair, where Spiderwort’s CelluBridge TM product received a Breakthrough Device Designation from the FDA.

Presenter: Stephen Hanson, PhD, MBA, Director of Business Development

Learn More.


StimuSIL is the non-invasive alternative to hair transplantation. It uses a patented medical device to deliver photobiostimulation directly to the hair follicle.

The treatment is completely non-invasive, aiming to be competitive with today’s treatments. It is a painless lunchtime procedure, offering aesthetic clinics a new revenue line for existing and new customers.

The untreated hair regrowth market is larger than the treated market, due to the lack of treatments that are both convenient and effective. StimuSIL will be to hair transplants what Botox® has been for facelifts – a non-invasive option that drastically grows the market.

StimuSIL will go to market in 2024, aiming to become the leader in the $300bn hair regrowth market.

Presenter: Pablo Villalba, President

Learn More. 

Syntr Health Technologies

Syntr’s premise is to harness the power of the patient’s own fat tissue to treat aging-related conditions. The problem in the medical world today is that we have multiple solutions for each human ailment or condition versus a true platform technology that can target all at once. That is a major bottleneck to advancing the world of medicine and medical aesthetics. Syntr Health Technologies provides the only FDA-cleared automated platform technology to process a patient’s own fat tissue to aid in healing and rejuvenation.

Presenter: Ahmed Zobi, CEO

Learn More. 


TissueForm is passionate about improving life for people with volumetric tissue loss. TissueForm advances novel extracellular matrix-based biomaterials to address clinical problems in plastic surgery and regenerative medicine. TissueForm’s first product, NatruDermeTM, is a dermal filler designed to mimic skin. It enters a $3.2B US filler market, where fillers are sold directly to providers. Today, patients who desire procedures for tissue loss using fillers must choose between products that are (1) natural but biologically inert and quickly degrading, or (2) semi-permanent but composed of plastic or synthetic materials. Instead, NatruDermeTM disrupts the tissue repair market by providing a natural and structural biomaterial that closely mimics skin, maximizes durability, minimizes swelling and migration, and is reversible. 

Presenter: Jeanne Barthold, Co-founder

Learn More. 

Yuva Biosciences, Inc.

YuvaBio is fighting aging, starting with hair and skin, by restoring mitochondrial function. Mitochondrial dysfunction is a key root cause of aging, and YuvaBio is solving this problem with a unique platform that identifies natural compounds that improve mitochondrial health. YuvaBio’s lead compound has already been licensed out and is already in clinical trials, and a pipeline of additional compounds is in place, generated with the help of our advanced AI model. Existing products address only the symptoms of skin and hair aging—it’s time to fight aging at the root cause through mitochondrial science!

Presenter: Greg Schmergel, CEO

Learn More. 

Ophthalmology Tech Forum 2024

Newport Beach Marriott Hotel & Spa 900 Newport Center Drive, Newport Beach, CA, United States

At Ophthalmology Tech Forum, industry, key opinion leaders, and top ophthalmologists discuss the future of the industry. The event is held annually in Orange County, the center for Ophthalmology in […]

Women Leaders of Octane Quarterly Meeting (July 2024)


Please join Women Leaders of Octane for our virtual quarterly meeting, Wednesday, July 17 from 12 – 1 pm PST, featuring our Spotlight Thought Leader, Paige Hendrix Buckner, CEO of […]

Contact Us


4041 MacArthur Blvd, Suite 260 Newport Beach, CA 92660


© 2024 Octane